RE
RedBaronRick
Community Contributor
Followers0Total number of followers
Comments0Total number of comments
Member Since2024Date joined
No bio added yet
No link added
RE
Community Contributor
Outlook Therapeutics will stay static with a 0% revenue change in the 5-year forecast
Rests on the FDA. With that said, OTLK was close to approval last round...
View narrativeUS$0
FV
n/aintrinsic discount0%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
about 1 month ago author updated this narrative